Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!
Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Latest Articles
- Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
- Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
- Plurilock (PLUR.V) lands $19 million deal, largest in their history
- Rex Resources (OWN.V) continues gearing up with BC gold property
- Saga Metals (SAGA.V) investors get a mature resource explorer with a ‘weak hands’ discount
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion California Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
Leave a Reply